Sökning: WFRF:(Lauermann Jorg)
> Lindahl Bertil >
Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function-a prespecified substudy from REDUCE-AMI
-
- Mars, Katarina (författare)
- Karolinska Inst, Sweden
-
- Humphries, Sophia (författare)
- Uppsala Univ, Sweden
-
- Leissner, Philip (författare)
- Uppsala Univ, Sweden
-
visa fler...
-
- Jonsson, Martin (författare)
- Karolinska Inst, Sweden,Uppsala Univ, Sweden
-
- Karlstrom, Patric (författare)
- Ryhov Cty Hosp, Sweden
-
- Lauermann, Jorg (författare)
- Ryhov Cty Hosp, Sweden
-
- Alfredsson, Joakim (författare)
- Linköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US
-
- Kellerth, Thomas (författare)
- Centralsjukhuset Karlstad, Sweden
-
- Ravn-Fischer, Annica, 1974 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Sahlgrens Univ Hosp, Sweden; Univ Gothenburg, Sweden
-
- Erlinge, David (författare)
- Lund Univ, Sweden
-
- Lindahl, Bertil (författare)
- Uppsala Univ, Sweden; Uppsala Univ, Sweden
-
- Yndigegn, Troels (författare)
- Lund Univ, Sweden
-
- Jernberg, Tomas (författare)
- Danderyd Hosp, Sweden
-
- Held, Claes (författare)
- Uppsala Univ, Sweden; Uppsala Univ, Sweden
-
- Olsson, Erik M. G. (författare)
- Uppsala Univ, Sweden
-
- Hofmann, Robin (författare)
- Karolinska Inst, Sweden
-
visa färre...
-
(creator_code:org_t)
- 2024
- Engelska.
-
Ingår i: European Heart Journal - Cardiovascular Pharmacotherapy. - : OXFORD UNIV PRESS. - 2055-6837 .- 2055-6845.
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
https://gup.ub.gu.se...
-
visa färre...
Abstract
Ämnesord
Stäng
- Aims In the Randomized Evaluation of Decreased Usage of Beta-Blockers after Acute Myocardial Infarction (REDUCE-AMI) study, long-term beta-blocker use in patients after acute myocardial infarction (AMI) with preserved left ventricular ejection fraction demonstrated no effect on death or cardiovascular outcomes. The aim of this prespecified substudy was to investigate effects of beta-blockers on self-reported quality of life and well-being. Methods and results From this parallel-group, open-label, registry-based randomized clinical trial, EQ-5D, and World Health Organization well-being index-5 (WHO-5) questionnaires were obtained at 6-10 weeks and 11-13 months after AMI in 4080 and 806 patients, respectively. We report results from intention-to-treat and on-treatment analyses for the overall population and relevant subgroups using Wilcoxon rank sum test and adjusted ordinal regression analyses. Of the 4080 individuals reporting EQ-5D (median age 64 years, 22% female), 2023 were randomized to beta-blockers. The main outcome, median EQ-5D index score, was 0.94 [interquartile range (IQR) 0.88, 0.97] in the beta-blocker group, and 0.94 (IQR 0.88, 0.97) in the no-beta-blocker group 6-10 weeks after AMI, OR 1.00 [95% CI 0.89-1.13; P > 0.9]. After 11-13 months, results remained unchanged. Findings were robust in on-treatment analyses and across relevant subgroups. Secondary outcomes, EQ-VAS and WHO-5 index score, confirmed these results. Conclusion Among patients after AMI with preserved left ventricular ejection fraction, self-reported quality of life and well-being was not significantly different in individuals randomized to routine long-term beta-blocker therapy as compared to individuals with no beta-blocker use. These results appear consistent regardless of adherence to randomized treatment and across subgroups which emphasizes the need for a careful individual risk-benefit evaluation prior to initiation of beta-blocker treatment.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- AMI: Acute myocardial infarction; EQ-VAS: EuroQoL visual analogue scale; EQ-5D: EuroQoL 5-dimension; LVEF: Left ventricular ejection fraction; QoL: Quality of life; SWEDEHEART: Swedish Web System for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies; WHO-5: World Health Organization-5
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)